Life Science Software Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The life science software market size has grown rapidly in recent years. It will grow from $22.31 billion in 2024 to $25.46 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to regulatory compliance requirements, data integration and management needs, rising demand for personalized medicine, globalization of clinical trials, patient-centric approaches.

The life science software market size is expected to see rapid growth in the next few years. It will grow to $43.28 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increased emphasis on real-world evidence (rwe), enhanced cybersecurity measures, integration of artificial intelligence (AI) and machine learning (ml), growing demand for cloud-based solutions, expanded role in precision medicine. Major trends in the forecast period include continued technological advancements, accelerated digital transformation, collaboration and networking, increasing research and development activities, advancements in technology.

The growing demand for personalized medicine is expected to drive the expansion of the life science software market in the coming years. Personalized medicine involves tailoring healthcare decisions and treatments based on an individual's unique characteristics, such as genetics, lifestyle, and environmental factors. To support this approach, advanced software solutions are necessary to standardize and integrate data from various sources, including wearable devices, genetic tests, and electronic health records. Life science software plays a critical role in analyzing and interpreting complex biological data, helping researchers and healthcare professionals customize treatment plans for individual patients. For example, a February 2023 report from the Personalized Medicine Coalition (PMC), a U.S.-based nonprofit, highlighted that personalized medicines accounted for 35% of newly approved New Molecular Entities (NMEs) in 2021. With 12 new approvals in 2022, they have consistently represented at least 25% of new drug approvals over the past eight years, a substantial increase from under 10% a decade ago. Therefore, the rising demand for personalized medicine is fueling the growth of the life science software market.

Prominent companies in the life science software market are incorporating advanced technologies, such as generative AI, machine learning (ML), and computer-aided drug design (CADD), to enhance the drug discovery process, improve efficiency, and expedite breakthroughs. Generative AI is utilized for designing novel molecular structures, while ML algorithms analyze extensive datasets to identify potential drug candidates and predict their efficacy. Integrated with CADD tools, these technologies enable researchers to computationally simulate and optimize drug interactions, significantly expediting the identification and development of promising compounds. In December 2023, Merck, a Germany-based science and technology company, introduced AIDDISON, a drug discovery software leveraging artificial intelligence (AI) and machine learning (ML) technologies. AIDDISON aims to accelerate the identification of novel medications and enhance the efficiency of the drug development process by evaluating massive volumes of data to identify prospective medication candidates more rapidly and effectively than traditional approaches.

In August 2024, Valsoft Corporation Inc., a Canada-based company specializing in acquiring and developing vertical market software businesses, acquired Anju Software for an undisclosed amount. This acquisition is aimed at strengthening Valsoft's position in the life sciences sector and expanding its portfolio with flexible solutions for clinical research, medical affairs, and data science. Anju Software, a U.S.-based company, is known for designing and developing software platforms tailored for the life sciences industry.

Major companies operating in the life science software market report are Meta Platforms Inc., Optum Inc., International Business Machines Corp., Deloitte, Thermo Fisher Scientific Inc., Oracle, SAP, Fujitsu Ltd., Cognizant, DXC Technology Co, HCL Technologies Ltd., Dassault Systèmes, EPIC Systems Corporation, SAS Institute Inc., INFOR, PAREXEL International Corporation, MEDICAL Information Technology Inc., Veeva Systems Inc., TIBCO Software Inc., PTC Therapeutics Inc., Cegedim SA, CPSI, Model N Inc., Medidata Solution Inc., ArisGlobal LLC, Perceptive Informatics Inc., Elinext, Signiant Inc., Allscripts Healthcare LLC, Jag products LLC.

North America was the largest region in the life science software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the life science software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The life science software market includes revenues earned by entities by providing services such as genomic analysis services, clinical trial management services, laboratory information management system (LIMS) services, bioinformatics and computational biology services, drug discovery and development services, and regulatory compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The Life Science Software market consists of sales of laboratory information management systems, electronic lab notebooks, scientific data analysis and visualization software, and scientific modeling and simulation software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Life science software encompasses specialized applications and platforms crafted to optimize and facilitate diverse processes within the life sciences sector. Widely employed across various domains in the industry, these software solutions aim to bolster research, streamline operations, and enhance overall efficiency.

Life science software can be categorized into three main types, predictive, descriptive, and prescriptive. Predictive software employs predictive analytics and can be deployed either on-premise or hosted. Its applications span across diverse areas such as marketing, compliance, research and development (R&D), pharmacovigilance, and supply chain management (SCM). This type of software finds utility in various end-user sectors, including healthcare institutes, the biopharmaceutical industry, the medical devices industry, and medical research centers.

The life science software market research report is one of a series of new reports that provides life science software market statistics, including life science software industry global market size, regional shares, competitors with life science software market share, detailed life science software market segments, market trends, and opportunities, and any further data you may need to thrive in the life science software industry. This life science software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.